Drug industry antitrust act. Hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs and for other purposes.

Volumes:

There are no volumes